Tandem Diabetes Care (TNDM) EPS (Basic) Growth (5y) (2018 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) EPS (Basic) Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 803.45 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.81% |
| Mar 31, 2026 | -29.68% |
| Dec 31, 2025 | -15.20% |
| Sep 30, 2025 | -15.29% |
| Jun 30, 2025 | -11.75% |
| Mar 31, 2025 | -51.14% |
| Dec 31, 2024 | -23.55% |
| Sep 30, 2024 | -48.37% |
| Jun 30, 2024 | -78.80% |
| Mar 31, 2024 | -10.45% |
| Dec 31, 2023 | -51.65% |
| Sep 30, 2023 | 3.84% |
| Jun 30, 2023 | -15.47% |
| Mar 31, 2023 | -17.54% |
| Dec 31, 2022 | 31.82% |
| Sep 30, 2022 | 21.30% |
| Jun 30, 2022 | 42.59% |
| Mar 31, 2022 | 48.94% |
| Dec 31, 2021 | 15.32% |
| Sep 30, 2021 | 14.98% |